IMARC Group, a leading market research company, has recently releases report titled “Gene Synthesis Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028” The study provides a detailed analysis of the industry, including the global gene synthesis market share, size, trends, and growth forecasts. The report also includes competitor and regional analysis and highlights the latest advancements in the market.

Report Highlights

How big is the gene synthesis market?

What is gene synthesis?

Gene synthesis is an essential tool in genetic engineering, which involves the creation of desired deoxyribonucleic acid (DNA) sequences by assembling nucleotides in a specific order in a laboratory. It is a specific technology that lets researchers generate DNA sequences customized to their specific research requirements and can be scaled up for use in experiments or larger production processes. It is also used to introduce specific mutations into existing genes or create DNA fragments that can be cloned and expressed, ultimately producing synthetic genes that encode proteins with specific characteristics, such as increased stability or activity. As a result, gene synthesis is widely adopted in biotechnology and pharmaceutical companies, academic and government research institutes, and contract research organizations.

Request for a free sample copy of this report: https://www.imarcgroup.com/gene-synthesis-market/requestsample

What are the growth prospects and trends in the gene synthesis market?

The market is primarily driven by the increasing prevalence of chronic ailments such as cancer and tumors. In addition, the surging need for effective drugs and vaccines to combat such illnesses and develop effective treatments is contributing to the market growth. Moreover, several innovations in DNA synthesis techniques, such as the incorporation of artificial intelligence (AI) and computer-aided design (CAD) tools to provide higher accuracy, facilitate faster turnaround times, and the synthesis of longer DNA sequences represents another major growth-inducing factor. Besides this, the increasing government investment supporting gene editing technologies, genetically modified (GM) crop production, and gene therapeutics are accelerating the product adoption rate. Furthermore, the escalating demand for synthetic genes in various biotechnology fields, continuous advancement in synthetic biology and genome editing technologies, and extensive research and development (R&D) activities are creating a positive global market outlook.

What is included in market segmentation?

The report has segmented the market into the following categories:

Method Insights: 

• Solid-Phase Synthesis
• Chip-Based Synthesis 
• PCR-Based Enzyme Synthesis

Services Insights: 

• Antibody DNA Synthesis
• Viral DNA Synthesis
• Others

Application Insights: 

• Gene and Cell Therapy Development
• Vaccine Development
• Disease Diagnosis
• Others

End Use Insights: 

• Biotechnology and Pharmaceutical Companies
• Academic and Government Research Institutes
• Contract Research Organizations

Breakup by Geography:

• North America (United States, Canada)
• Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, Others)
• Europe (Germany, France, United Kingdom, Italy, Spain, Russia, Others)
• Latin America (Brazil, Mexico, Others)
• Middle East and Africa

Who are the key players operating in the industry?

The report covers the major market players including:

• ATUM
• Boster Biological Technology
• Eurofins Genomics
• Genewiz Inc. (Azenta Life Sciences)
• Genscript Biotech Corp.
• Integrated DNA Technologies Inc.
• Merck KGaA
• OriGene Technologies Inc.
• ProMab Biotechnologies Inc.
• ProteoGenix Inc
• Thermo Fisher Scientific Inc.
• Twist Bioscience etc

Ask Analyst for Customization and Browse full report with TOC & List of Figure: https://www.imarcgroup.com/request?type=report&id=7159&flag=C

If you require any specific information that is not covered currently within the scope of the report, we will provide the same as a part of the customization.

About Us

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC Group’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

Contact US

IMARC Group

134 N 4th St. Brooklyn, NY 11249, USA

USA: +1-631-791-1145 | Asia: +91-120-433-0800

Email: [email protected]

Follow us on Twitter: @imarcglobal

LinkedIn: https://www.linkedin.com/company/imarc-group/mycompany/